Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy

Abstract Background Cancer therapy-related cardiac dysfunction (CTRCD) is a critical problem with an impact on both oncological and cardiovascular prognosis, especially when it prevents patients from receiving cancer treatment. Standard therapy for heart failure (HF) is recommended for CTRCD, but th...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Vanesa Gregorietti, Teresa Lopez Fernandez, Diego Costa, Elías Ortega Chahla, Andrés J. Daniele
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2020-11-01
Edice:Cardio-Oncology
Témata:
Heart failure
Cancer
Cardiotoxicity
Sacubitril/valsartan
On-line přístup:http://link.springer.com/article/10.1186/s40959-020-00078-4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky